This program is supported in part by an independent medical educational grant from Mylan Specialty L.P.
On-demand CE Webinar
Erin Dorval, PharmD
Assistant Professor of Pharmacy Practice
Palm Beach Atlantic University
Gregory School of Pharmacy
West Palm Beach, Florida
Given the very nature of anaphylaxis being a medical emergency that requires immediate recognition and treatment, it is imperative for convenient care providers (CCPs) and pharmacists to be able to recognize the signs and symptoms associated with anaphylaxis to ensure that the affected patient is treated both promptly and appropriately. CCPs and pharmacists are ideally positioned to identify and assist patients at risk for anaphylactic reactions. This activity will differentiate between allergic and nonallergic anaphylaxis, and explore the available treatment options. Effective team-based treatment and preventive strategies will also be analyzed to ensure patients understand proper technique for using an epinephrine auto-injector as well as the initial steps for immediate care following administration of the first dose of epinephrine.
At the completion of this activity, the participant will be able to:
Explore the etiology of anaphylaxis, differentiate between allergic and nonallergic anaphylaxis, and examine the common causes or risk factors
Explain the mechanism of action of epinephrine in the treatment of anaphylaxis, potential adverse effects, and monitoring parameters
Analyze effective team-based treatment and preventive strategies to ensure patients understand proper technique for using an epinephrine auto-injector
Convenient care nurse practitioners and retail pharmacists
Type of Activity:
November 30, 2017
November 30, 2018
Nurse Practitioner Accreditation
This activity is approved for 1.0 contact hour of continuing education (which includes 1.0 hour of pharmacology) by the American Association of Nurse Practitioners. Activity ID 17102890. This activity was planned in accordance with AANP CE Standards and Policies.
How to Obtain AANP Credit
To receive credit, nurse practitioners must complete the online pre-assessment polling questions, view the webinar, and complete the online post-assessment questions and activity evaluation form. After successful completion of the evaluation form, you may request your credit. All participants must request credit before November 30, 2018.
Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.1 CEU) under the ACPE universal activity number 0290-0000-17-154-H01-P. The activity is available for CE credit through November 30, 2018.
How to Obtain ACPE Credit
To receive credit, pharmacists must complete the online pre-assessment polling questions, view the webinar in its entirety, and complete the online post-assessment questions and activity evaluation form. After successful completion of the evaluation form, your credit will be uploaded to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before November 30, 2018.
Disclosure of Conflicts of Interest
PER® requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PER® for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The following contributors have no relevant financial relationships with commercial interests to disclose:
Erin Dorval, PharmD
Physicians' Education Resource®, LLC (PER®)
Planning Staff – David Heckard; Maryjo Dixon, RPh; Oliver Mills, PharmD, RPh; Donna Fausak; Olivia Mastrodonato; and Susan Pordon
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PER® does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Required: Windows 7, Vista, XP, 2003 Server or 2000
Required: Mac OS X 10.4.11 (Tiger) or newer
For questions about this Internet CPE activity, please contact: email@example.com